Effects of bupivacaine on human erythrocytes submitted to stress and evidence for an interaction between bupivacaine and flumazenil

7Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Aims. To examine the effects of bupivacaine on erythrocytes submitted to an oxidative stress (AAPH) and to provide evidence for an in vitro interaction between bupivacaine and flumazenil. Methods. Human erythrocytes were studied with or without AAPH in the presence of different concentrations of bupivacaine (0.15, 0.3, 0.9 and 1.8 mmol l-1), or flumazenil (0.16 mmol l-1) and with the association of flumazenil and two doses of bupivacaine (0.15 and 0.3 mmol l-1). Potassium efflux was measured by flame photometry at t0, and every 30 min for 2 h. Results. In the absence of AAPH, extracellular potassium remained unchanged. Oxidative stress induced a significant increase in extracellular potassium, which was not modified by incubation with flumazenil. Bupivacaine significantly lowered the increase in extracellular potassium in a dose-related fashion. The association with flumazenil blunted the effects of bupivacaine. Discussion. In this model, bupivacaine proved effective in protecting erythrocytess against oxidative stress. Flumazenil interacted with bupivacaine and blunted its protective effects.

Cite

CITATION STYLE

APA

Lenfant, F., Lahet, J. J., Volot, F., Schafer, I., Freysz, M., & Rochette, L. (1999). Effects of bupivacaine on human erythrocytes submitted to stress and evidence for an interaction between bupivacaine and flumazenil. British Journal of Clinical Pharmacology, 48(6), 826–828. https://doi.org/10.1046/j.1365-2125.1999.00083.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free